PT82651A - Process for preparing synthetic vaccines for foot and mouth disease based on peptides - Google Patents

Process for preparing synthetic vaccines for foot and mouth disease based on peptides

Info

Publication number
PT82651A
PT82651A PT82651A PT8265186A PT82651A PT 82651 A PT82651 A PT 82651A PT 82651 A PT82651 A PT 82651A PT 8265186 A PT8265186 A PT 8265186A PT 82651 A PT82651 A PT 82651A
Authority
PT
Portugal
Prior art keywords
peptides
foot
mouth disease
disease based
preparing synthetic
Prior art date
Application number
PT82651A
Other languages
English (en)
Other versions
PT82651B (pt
Inventor
Richard Dennis Dimarchi
Gerald Stephen Brooke
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PT82651A publication Critical patent/PT82651A/pt
Publication of PT82651B publication Critical patent/PT82651B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/222—Foot and mouth disease related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT82651A 1985-06-03 1986-05-27 Processo para a preparacao de vacinas sintenticas para a febre aftosa a base de peptideos PT82651B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74078085A 1985-06-03 1985-06-03

Publications (2)

Publication Number Publication Date
PT82651A true PT82651A (en) 1986-06-01
PT82651B PT82651B (pt) 1988-11-30

Family

ID=24978033

Family Applications (1)

Application Number Title Priority Date Filing Date
PT82651A PT82651B (pt) 1985-06-03 1986-05-27 Processo para a preparacao de vacinas sintenticas para a febre aftosa a base de peptideos

Country Status (20)

Country Link
US (1) US4732971A (pt)
EP (1) EP0204480B1 (pt)
JP (1) JPS61282398A (pt)
KR (1) KR890003944B1 (pt)
CN (1) CN1019267B (pt)
AT (1) AT396248B (pt)
AU (1) AU595531B2 (pt)
DE (1) DE3686095T2 (pt)
DK (1) DK251286A (pt)
EG (1) EG17812A (pt)
ES (1) ES8707739A1 (pt)
GR (1) GR861406B (pt)
HK (1) HK101692A (pt)
HU (1) HUT41050A (pt)
IL (1) IL78913A (pt)
NZ (1) NZ216362A (pt)
PT (1) PT82651B (pt)
SG (1) SG94792G (pt)
SU (1) SU1662338A3 (pt)
ZA (1) ZA863911B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6024964A (en) * 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US6074650A (en) * 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US5864008A (en) * 1988-03-25 1999-01-26 James; Stephen Peptides derived from foot-and-mouth disease virus, pharmaceutical compositions, and methods for using the peptides
ZW6189A1 (en) * 1988-05-09 1990-05-09 Smithkline Beckman Corp Anti-aggregatory peptides
CN1059347C (zh) * 1992-03-27 2000-12-13 牧岩生命工学研究所 制备肾病综合症出血热疫苗的方法
CN1054544C (zh) * 1993-10-21 2000-07-19 复旦大学 家畜口蹄疫病毒多肽疫苗及其制备方法
US5538733A (en) * 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US6096863A (en) * 1996-08-23 2000-08-01 Regents Of The University Of Minnesota Self-assembling amphiphiles for construction of peptide secondary structures
DE19638044A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Immunogene Peptide von Maul- und Klauenseuchen-Viren
US6048538A (en) * 1997-10-03 2000-04-11 United Biomedical, Inc. Peptides derived from the non-structural proteins of foot and mouth disease virus as diagnostic reagents
KR100620935B1 (ko) 1998-03-19 2006-09-13 브리스톨-마이어스스퀴브컴파니 용해도가 높은 약물에 대한 2상 서방성 전달 시스템과 방법
US6107021A (en) 1998-06-20 2000-08-22 United Biomedical, Inc. Synthetic peptide vaccines for foot-and-mouth disease
US8058248B2 (en) * 2001-04-26 2011-11-15 The United States Of America As Represented By The Secretary Of Agriculture Foot and mouth disease virus vaccine comprising interferons
CN100342911C (zh) * 2004-01-13 2007-10-17 厦门大学 A、o型口蹄疫病毒双价dna疫苗及其制备方法
NZ591810A (en) 2008-09-17 2012-12-21 Chiasma Inc Pharmaceutical compositions and related methods of delivery the composition comprises a medium chain fatty acid
JP6042330B2 (ja) 2010-07-09 2016-12-14 ビーエイチヴィ ファーマ、インコーポレイテッド レモグリフロジンを含めた半減期が短い医薬品のための組合せ即時／遅延放出送達システム
BR112015010756B1 (pt) 2012-11-16 2022-04-12 United Biomedical, Inc Composições de vacina para a doença do pé-e-boca (fmd),e uso das mesmas
HRP20230752T1 (hr) 2015-01-16 2023-10-27 Zoetis Services Llc Cjepivo protiv slinavke i šapa
MA41462A (fr) 2015-02-03 2021-05-12 Chiasma Inc Méthode de traitement de maladies
CN107365367A (zh) * 2017-08-16 2017-11-21 山东省农业科学院奶牛研究中心 A型口蹄疫病毒vp1蛋白抗原表位基因多肽及其应用
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
WO2022221144A1 (en) * 2021-04-12 2022-10-20 University Of Washington Engineered peptides for αvβ6 integrin binding and related methods of use and synthesis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140763A (en) * 1976-09-08 1979-02-20 The United States Of America As Represented By The Secretary Of Agriculture Vaccine for foot and mouth disease
AU547096B2 (en) * 1980-05-12 1985-10-03 Biogen N.V. Foot-and mouth disease viral antigens
EP0068693A3 (en) * 1981-06-16 1983-07-20 Genentech, Inc. Production of foot and mouth disease vaccine from microbially expressed antigens
ZA831854B (en) * 1982-03-26 1984-01-25 Biogen Nv Small peptides with the specificity of foot and mouth disease viral antigens
DE3382459D1 (de) 1982-04-14 1991-12-19 James L Bittle Kuenstliches pikornavirusantigen.

Also Published As

Publication number Publication date
DK251286D0 (da) 1986-05-29
AU5821286A (en) 1986-12-11
IL78913A (en) 1991-01-31
AT396248B (de) 1993-07-26
HUT41050A (en) 1987-03-30
DE3686095T2 (de) 1993-03-04
EP0204480A3 (en) 1989-02-08
JPS61282398A (ja) 1986-12-12
HK101692A (en) 1992-12-24
EP0204480B1 (en) 1992-07-22
US4732971A (en) 1988-03-22
NZ216362A (en) 1989-04-26
ES555668A0 (es) 1987-08-16
GR861406B (en) 1986-09-30
SU1662338A3 (ru) 1991-07-07
IL78913A0 (en) 1986-09-30
DK251286A (da) 1986-12-04
EG17812A (en) 1990-08-30
ZA863911B (en) 1988-01-27
ATA141786A (de) 1992-11-15
CN86103718A (zh) 1987-02-04
CN1019267B (zh) 1992-12-02
KR870000426A (ko) 1987-02-18
PT82651B (pt) 1988-11-30
SG94792G (en) 1992-12-04
AU595531B2 (en) 1990-04-05
DE3686095D1 (de) 1992-08-27
EP0204480A2 (en) 1986-12-10
KR890003944B1 (ko) 1989-10-13
ES8707739A1 (es) 1987-08-16

Similar Documents

Publication Publication Date Title
PT82651A (en) Process for preparing synthetic vaccines for foot and mouth disease based on peptides
IL78775A (en) Oral vaccines
GB8907914D0 (en) Vaccine preparation
YU113889A (en) Process for obtaining recombinant vaccine for coccidiosis
EP0256878A3 (en) Vaccines
YU109089A (en) Cyclical peptides and process for obtaining thereof
ZA88149B (en) Anti-reproductive vaccines
IL77534A (en) Growth hormone-releasing peptides and process for their preparation
PT85221A (en) Improved stabilizers for live vaccines process for their preparation and vaccines containing them
EP0285173A3 (en) Human tumour-associated antigen
ZA892954B (en) A synthetic vaccine against foot and mouth disease and a process for the preparation thereof
YU6889A (en) Process for obtaining recombinant human interleukin-1-alpha-polypeptide
ZA881337B (en) Synthetic anti-caries vaccine
PH24366A (en) Synthetic vaccines for foot and mouth disease
GB8615068D0 (en) Vaccines
IE880547L (en) Synthetic anti-caries vaccine
ZA863612B (en) Oral vaccines
GB8605646D0 (en) Vaccines
IE872351L (en) Antigenic proteins
FI101603B1 (fi) Menetelmä rokotteen valmistamiseksi siipikarjan tarttuvaa bursaalitautia vastaan
BG43444A1 (en) Peptides and method for their preparation
RO101947B1 (en) Marek's disease vaccine and preparation method
ZA883365B (en) Newcastle disease virus vaccine and method for the application thereof
GB8828523D0 (en) St-lt recombinant antigen vaccines
GB8725519D0 (en) Vaccines

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19931031